$CNTX
Context Therapeutics Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$0.316
▼-1.74%-$0.006
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateContext Therapeutics Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is CNTX down today? It is at $0.316 (-1.74%), and our scanner flagged it 19 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CNTX spikes, and full due diligence on CNTX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CNTX 19 times in the last 30 days. Create a free account to track $CNTX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CNTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CNTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystAugust 2026 Corporate Presentation Advancing T Cell Engagers for Solid Tumors, from an SEC filing. Read it →Latest filingSC 13G/APassive 5%+ stake updatedAug 14, 2026 · 54 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Lehr Martin A. Officer | Bought (open market) | +100K 0.1% of company | added 12% | 920K | $70K at $0.700 | Jun 9, 25 |
Minai-Azary Jennifer Lynn Officer | Bought (open market) | +40K 0.04% of company | added 100% | 80K | $26K at $0.640 | Jun 6, 25 |
Levit Alex C. Officer | Bought (open market) | +20K 0.02% of company | added 100% | 29K | $12K at $0.580 | Jun 6, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on CNTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CNTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
CNTX last traded at $0.316, down 1.74% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Context Therapeutics Inc. Common Stock (CNTX) is next expected to report earnings on Wednesday, November 4, 2026, about 28 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The CNTX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CNTX 19 times in the last 30 days.
CNTX (Context Therapeutics Inc. Common Stock) trades on XNAS, with a market cap of about $30M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CNTX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CNTX discussion
Sign in to ask a question or join the discussion.